openPR Logo

Press Releases from DelveInsight Business Research LLP (4878 total)

Postoperative Pain Clinical and Non-Clinical Studies, Key Companies, Therapeutic …

Postoperative Pain Pipeline constitutes 45+ key companies continuously working towards developing 50+ Postoperative Pain treatment therapies, analyzes DelveInsight. Postoperative Pain Overview: Postoperative or postsurgical pain is defined

Polymyalgia Rheumatica Clinical and Non-Clinical Studies, Key Companies, Therape …

Polymyalgia Rheumatica Pipeline constitutes 5+ key companies continuously working towards developing 5+ Polymyalgia Rheumatica treatment therapies, analyzes DelveInsight. Polymyalgia Rheumatica Overview: Polymyalgia rheumatica (PMR) is a rheumatic

Peripheral t cell lymphomas (PTCL) Clinical and Non-Clinical Studies, Key Compan …

Peripheral t cell lymphomas (PTCL) Pipeline constitutes 40+ key companies continuously working towards developing 40+ Peripheral t cell lymphomas (PTCL) treatment therapies, analyzes DelveInsight. Peripheral t

Spinocerebellar Ataxias Clinical and Non-Clinical Studies, Key Companies, Therap …

Spinocerebellar Ataxias Pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analyzes DelveInsight. Spinocerebellar Ataxias Overview: Ataxia refers to the lack of

Progressive Multifocal Leukoencephalopathy Clinical and Non-Clinical Studies, Ke …

Progressive Multifocal Leukoencephalopathy Pipeline constitutes 3+ key companies continuously working towards developing 3+ Progressive Multifocal Leukoencephalopathy treatment therapies, analyzes DelveInsight. Progressive Multifocal Leukoencephalopathy Overview: Progressive multifocal leukoencephalopathy

Chronic Inflammatory Demyelinating Polyneuropathy Clinical and Non-Clinical Stud …

Chronic Inflammatory Demyelinating Polyneuropathy Pipeline constitutes 2+ key companies continuously working towards developing 4+ Chronic Inflammatory Demyelinating Polyneuropathy treatment therapies, analyzes DelveInsight. Chronic Inflammatory Demyelinating Polyneuropathy

Lennox Gastaut Syndrome Clinical and Non-Clinical Studies, Key Companies, Therap …

Lennox Gastaut Syndrome Pipeline constitutes 10+ key companies continuously working towards developing 10+ Lennox Gastaut Syndrome treatment therapies, analyzes DelveInsight. Lennox Gastaut Syndrome Overview: Lennox-Gastaut syndrome (LGS)

Hypothalamic Obesity Market: Analysis of Epidemiology, Pipeline Products, and Ke …

Hypothalamic Obesity emerging therapies such as LB54640, and others are expected to boost the Hypothalamic Obesity Market in the upcoming years. DelveInsight has launched a new

Equine Encephalitis Clinical and Non-Clinical Studies, Key Companies, Therapeuti …

Equine Encephalitis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Equine Encephalitis treatment therapies, analyzes DelveInsight. Equine Encephalitis Overview: Western, Eastern, and Venezuelan equine encephalitis

ALK Positive Metastatic NSCLC Treatment Market Size in 7MM is expected to grow a …

DelveInsight's "ALK Positive Metastatic NSCLC Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the ALK Positive Metastatic NSCLC, historical and forecasted

Cancer Cachexia Treatment Market Size in 7MM is expected to grow at a decent CAG …

DelveInsight's "Cancer Cachexia Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Cancer Cachexia, historical and forecasted epidemiology as well as

Pompe Disease Treatment Market Size in 7MM is expected to grow at a decent CAGR …

DelveInsight's "Pompe disease Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the indication Pompe disease, historical and forecasted epidemiology

Multiple System Atrophy Treatment Market Size in 7MM is expected to grow at a de …

DelveInsight's "Multiple System Atrophy Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of MSA, historical and forecasted epidemiology, as well

Krabbe Disease Treatment Market Size in 7MM is expected to grow at a decent CAGR …

DelveInsight's "Krabbe Disease Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Krabbe Disease, historical and forecasted epidemiology as well as

Insomnia Treatment Market Size in 7MM is expected to grow at a decent CAGR by 20 …

DelveInsight's "Insomnia Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Insomnia, historical and forecasted epidemiology as well as

Postpartum Depression Clinical and Non-Clinical Studies, Key Companies, Therapeu …

Postpartum Depression Pipeline constitutes 10+ key companies continuously working towards developing 10+ Postpartum Depression treatment therapies, analyzes DelveInsight. Postpartum Depression Overview: Postpartum depression (PPD) is a significant

Psychosis in Parkinson's and Alzheimer's Disease Market: Analysis of Epidemiolog …

Psychosis in Parkinson's and Alzheimer's Disease emerging therapies such as NUPLAZID (pimavanserin), Ulotaront (SEP-363856), KarXT (xanomeline-trospium), ITI-1284, and others are expected to boost the Psychosis

Focal Epilepsy Market: Analysis of Epidemiology, Pipeline Products, and Key Comp …

Focal Epilepsy emerging therapies are expected to boost the Focal Epilepsy Market in the upcoming years. DelveInsight has launched a new report on "Focal Epilepsy -

Alzheimer's Disease Clinical and Non-Clinical Studies, Key Companies, Therapeuti …

Alzheimer's Disease Pipeline constitutes 110+ key companies continuously working towards developing 120+ Alzheimer's Disease treatment therapies, analyzes DelveInsight. Alzheimer's Disease Overview: Alzheimer's disease (AD) is a **neurodegenerative

Agitation in Alzheimer's Disease Market: Analysis of Epidemiology, Pipeline Prod …

Agitation in Alzheimer's Disease emerging therapies such as TransCon hGH, HyTropin (GX-H9), Somatrogon, and others are expected to boost the Agitation in Alzheimer's Disease Market

Cell and Gene Therapy in Parkinson's Disease Clinical and Non-Clinical Studies, …

Cell and Gene Therapy in Parkinson's Disease Pipeline constitutes 18+ key companies continuously working towards developing 20+ Cell and Gene Therapy in Parkinson's Disease treatment

Diabetic Neuropathy Clinical and Non-Clinical Studies, Key Companies, Therapeuti …

Diabetic Neuropathy Pipeline constitutes 20+ key companies continuously working towards developing 25+ Diabetic Neuropathy treatment therapies, analyzes DelveInsight. Diabetic Neuropathy Overview: Diabetic neuropathy is a form of

Chronic Pain Associated with Painful Diabetic Neuropathy Market: Analysis of Epi …

Chronic Pain Associated with Painful Diabetic Neuropathy emerging therapies such are expected to boost the Chronic Pain Associated with Painful Diabetic Neuropathy Market in the

Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Market, Clinical and Non-Clinical …

Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Pipeline constitutes key companies continuously working towards developing Neuronal Ceroid-Lipofuscinoses (CLN1 disease) treatment therapies, analyzes DelveInsight. Neuronal Ceroid-Lipofuscinoses (CLN1 disease) Overview: Neuronal Ceroid-Lipofuscinoses

Hemophilia Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism …

DelveInsight's, "Hemophilia Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Hemophilia pipeline landscape. It covers the Hemophilia pipeline

Hearing Loss Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechani …

DelveInsight's, "Hearing Loss Pipeline Insight 2025" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hearing Loss pipeline landscape. It covers the

Severe Asthma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechan …

DelveInsight's, "Severe Asthma Pipeline Insight 2025" report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Severe Asthma pipeline landscape. It covers the

Multiple sclerosis Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, M …

DelveInsight's, "Multiple sclerosis Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the

Triple Negative Breast Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA A …

DelveInsight's, "Triple Negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline

Schizophrenia Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechan …

DelveInsight's, "Schizophrenia Pipeline Insight" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the Schizophrenia pipeline drug

Parkinson's disease psychosis Clinical and Non-Clinical Studies, Key Companies, …

Parkinson's disease psychosis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's disease psychosis treatment therapies, analyzes DelveInsight. Parkinson's disease psychosis Overview: Nonmotor symptoms significantly

Asperger Syndrome Market: Analysis of Epidemiology, Pipeline Products, and Key C …

Asperger Syndrome emerging therapies are expected to boost the Asperger Syndrome Market in the upcoming years. DelveInsight has launched a new report on "Asperger Syndrome -

Motor Neuron Disease Clinical and Non-Clinical Studies, Key Companies, Therapeut …

Motor Neuron Disease Companies are Biohaven Pharmaceuticals, Inc., Prilenia Therapeutics, Helixmith Co., Ltd., Transposon Therapeutics, Inc., GeneCradle Therapeutics, Verge Genomics, QurAlis Corporation, Zydus Lifesciences Limited,

Mild Cognitive Impairment Market: Analysis of Epidemiology, Pipeline Products, a …

Mild Cognitive Impairment emerging therapies such as LEQEMBI (lecanemab), KISUNLA (Donanemab), and others are expected to boost the Mild Cognitive Impairment Market in the upcoming

Extensive-Stage Small Cell Lung Cancer (ESCLC) Clinical and Non-Clinical Studies …

Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline constitutes 25+ key companies continuously working towards developing 30+ Extensive-Stage Small Cell Lung Cancer (ESCLC) treatment therapies, analyzes

Primary Ciliary Dyskinesia Clinical and Non-Clinical Studies, Key Companies, The …

Primary Ciliary Dyskinesia Pipeline constitutes 4+ key companies continuously working towards developing 4+ Primary Ciliary Dyskinesia treatment therapies, analyzes DelveInsight. Primary Ciliary Dyskinesia Overview: Primary ciliary dyskinesia

Amyotrophic Lateral Sclerosis Clinical and Non-Clinical Studies, Key Companies, …

Amyotrophic Lateral Sclerosis Pipeline constitutes 75+ key companies continuously working towards developing 80+ Amyotrophic Lateral Sclerosis treatment therapies, analyzes DelveInsight. Amyotrophic Lateral Sclerosis Overview: Amyotrophic Lateral Sclerosis

Complex Regional Pain Syndrome Clinical and Non-Clinical Studies, Key Companies, …

Complex Regional Pain Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Complex Regional Pain Syndrome treatment therapies, analyzes DelveInsight. Complex Regional Pain Syndrome

Myelin Regeneration in Multiple Sclerosis Clinical and Non-Clinical Studies, Key …

Myelin Regeneration in Multiple Sclerosis Pipeline constitutes 25+ key companies continuously working towards developing 30+ Myelin Regeneration in Multiple Sclerosis treatment therapies, analyzes DelveInsight. Myelin Regeneration

Nerve Growth Factor Market: Analysis of Epidemiology, Pipeline Products, and Key …

Nerve Growth Factor emerging therapies are expected to boost the Nerve Growth Factor Market in the upcoming years. DelveInsight has launched a new report on "Nerve

Achondroplasia Treatment Market Size in 7MM is expected to grow at a decent CAGR …

DelveInsight's "Achondroplasia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia

Moderate To Severe Acute Pain Treatment Market Size in 7MM is expected to grow a …

DelveInsight's "Moderate To Severe Acute Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Moderate To Severe Acute Pain, historical

Leigh Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR …

DelveInsight's comprehensive report titled "Leigh Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" offers a detailed analysis of Leigh syndrome. The report presents historical

Cryptococcal Meningitis Treatment Market Size in 7MM is expected to grow at a de …

DelveInsight's "Cryptococcal Meningitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cryptococcal Meningitis, historical and forecasted epidemiology as well as

Chronic Traumatic Encephalopathy Treatment Market Size in 7MM is expected to gro …

DelveInsight's "Chronic Traumatic Encephalopathy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Traumatic Encephalopathy, historical and forecasted epidemiology as

Treatment Resistant Depression Treatment Market Size in 7MM is expected to grow …

DelveInsight's "Treatment Resistant Depression Market Insights, Epidemiology and Market Forecast - 2032" report delivers an in-depth understanding of historical and forecasted epidemiology as well as

Spastic Cerebral Palsy Treatment Market Size in 7MM is expected to grow at a dec …

DelveInsight's "Spastic Cerebral Palsy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Spastic Cerebral Palsy, historical and forecasted epidemiology as

Postoperative Pain Treatment Market Size in 7MM is expected to grow at a decent …

DelveInsight's "Postoperative Pain Drugs Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of postoperative pain, historical and forecasted epidemiology, as

Parkinson's Disease Psychosis Treatment Market Size in 7MM is expected to grow a …

DelveInsight's "Parkinson's Disease Psychosis (PDP) Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the PDP, historical and forecasted epidemiology

Generalized Anxiety Disorder Treatment Market Size in 7MM is expected to grow at …

DelveInsight's " Generalized Anxiety Disorder Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Generalized Anxiety Disorder, historical and forecasted epidemiology

Go To Page:    11 12 13 14 15 16 17 18 19 20